$0.17
+0.00 (+0.00%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+6,443.9% upside
Low Target
$8.32
Average Target
$11.19
High Target
$14.48
Current Price
$0.17
Current
$0.17
$0.17
Target
$11.19
$11.19
$8.32
$11.19 avg
$14.48
Scenario Analysis
Bear Case
$8.32
4,765.5%
Low target
Base Case
$11.19
+6,443.9%
Avg target
Bull Case
$14.48
+8,367.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$11.19
-88.3% vs high
Next Earnings Report
Nov 17, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.34
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |